Bronchiolitis

Archives of Disease in Childhood: Education and Practice Edition

Volumn 90, Issue 4, 2005, Pages

  Meates Dennis, Maud ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; DORNASE ALFA; HELIOX; HERBACEOUS AGENT; INTERFERON; IPRATROPIUM BROMIDE; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RETINOL; RIBAVIRIN; SALBUTAMOL; STEROID; SURFACTANT;

ANTIBIOTIC THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HAND WASHING; HUMAN; INFECTION PREVENTION; INFECTION RISK; OXYGEN THERAPY; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; VACCINATION; VIRAL BRONCHIOLITIS; WHEEZING;

EID: 28444450486     PISSN: 17430585     EISSN: None     Source Type: Journal    
DOI: 10.1136/adc.2004.067660     Document Type: Review

References (73)

1. Statistics HE. Bronchiolitis - statistics, http://www.wrongdiagnosis.com/ b/bronchiolitis/stats.htm (Accessed 6 December 2004).
2. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 2003;88:1065-69.
3. eMedicine. Bronchiolitis. http://www.emedicine.com/EMERG/topic365.htm (Accessed 7 February 2005).
4. Handforth J, Friedland JS, Sharland M. Basic epidemiology and immunopathology of RSV in children. Paediatric Respiratory Reviews 2000;1:210-14.
5. Centers for Disease Control and Prevention. RSV infection, http://www.cdc.gov/ncidod/dvrd/revb/respiratory/rsvfeat.htm (Accessed 6 December 2004).
6. Virology on line. Epidemiology of respiratory syncitial virus infections, http://virology-online.com/viruses/RSV2.htm (Accessed 25 January 2005).
7. Law BJ, Carbonell-Estrany X, Simoes EAF. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med 2002;96:S1-7.
8. Centers for Disease Control and Prevention. National Center for Infectious Diseases - respiratory syncitial virus, http://www.cdc.gov/ncidod/ dvrd/revb/nrevss/rsvfeat.htm (Accessed 17 December 2004).
9. Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004;350:443-50.
10. Bradley JP, Bacharier LB, Bonfiglio J, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005;115:E7-14.
11. Nielsen HE, Siersma V, Andersen S, et al. Respiratory syncytial virus infection-risk factors for hospital admission: a case-control study. Acta Paediatr 2003;92:1314-21.
12. Lahti M, Lofgren J, Marttila R, et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002;51:696-9.
13. Goetghebuer T, Isles K, Moore C, et al. Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004;34:801-3.
14. Blizzard LP, Ponsonby A-LP, Dwyer TMD, et al. Parental smoking and infant respiratory infection: how important is not smoking in the same room with the baby? Am J Public Health 2003;93:482-8.
15. Gurkan F, Kiral A, Dagli E, et al. The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis. Eur J Epidemiol 2000;16:465-8.
16. Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 2003;22(2 suppl):S18-20.
17. Kafetzis DA, Astro H, Tsolia M, et al. Otitis and respiratory distress episodes following a respiratory syncytial virus infection. Clin Microbiol Infect 2003;9:1006-10.
18. Levine DA, Platt SL, Dayan PS, et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 2004;113:1728-34.
19. Friis B, Andersen P, Brenoe E, et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child 1984;59:1038-45.
20. Farah MMM, Padgett LBM, McLario DJDM, et al. First-time wheezing in infants during respiratory syncytial virus season: chest radiograph findings. Pediatric Emergency Care 2002;18:333-6.
21. Abul-Ainine A, Luyt D. Short term effects of adrenaline in bronchiolitis: a randomised controlled trial. Arch Dis Child 2002;86:276-9.
22. Cooper AC, Banasiak NC, Allen PJ. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions. Pediatr Nurs 2003;29:452-6.
23. Dawson K. Rational prescribing for acute bronchiolitis. Pharmacoeconomics 1995;8:9-13.
24. King VJ, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med 2004;158:127-37.
25. Turner MO, Noertjojo K, Vedal S, et al. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998;157:1804-9.
26. Offer I, Ashkenazi S, Livni G, et al. The diagnostic and therapeutic approach to acute bronchiolitis in hospitalized children in Israel: a nationwide survey. Isr Med Assoc J 2000;2:108-10.
27. Plint AC, Johnson DW, Wiebe N, et al. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med 2004;11:353-60.
28. Cahill P, Finan E, Loftus BG. Management of bronchiolitis: current practices in Ireland. Ir Med J 2002;95:167-9.
29. Flores G, Horwitz RI. Efficacy of beta 2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997;100:233-9.
30. Kellner JD, Ohlsson A, Gadomski AM, et al. Bronchodilators for bronchiolitis. Cochrane Database of Systematic Reviews 2004;4:4.
31. Lozano JM. Bronchiolitis. London: BMJ Books, 2004.
32. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995;126:1004-7.
33. Numa AH, Williams GD, Dakin CJ. The effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolitis. Am J Respir Crit Care Med 2001;164:86-91.
34. Reijonen T, Korppi M, Pitkakangas S, et al. The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch Pediatr Adolesc Med 1995;149:686-92.
35. Ray MS, Singh V. Comparison of nebulized adrenaline versus salbutamol in wheeze associated respiratory tract infection in infants. Indian Pediatr 2002;39:12-22.
36. Lowell DI, Lister G, Von Koss H, et al. Wheezing in infants: the response to epinephrine. Pediatrics 1987;79:939-45.
37. Hariprakash S, Alexander J, Carroll W, et al. Randomized controlled trial of nebulized adrenaline in acute bronchiolitis. Pediatr Allergy Immunol 2003;14:134-9.
38. Sanchez I, De Koster J, Powell RE, et al. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr 1993;122:145-51.
39. Bertrand P, Aranibar H, Castro E, et al. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatr Pulmonol 2001;31:284-8.
40. Lodrup Carlsen KC, Carlsen KH. Inhaled nebulized adrenaline improves lung function in infants with acute bronchiolitis. Respir Med 2000;94:709-14.
41. Mull CC, Scarfone RJ, Ferri LR, et al. A randomized trial of nebulized epinephrine vs albuterol in the emergency department treatment of bronchiolitis.[see comment]. Arch Pediatr Adolesc Med 2004;158:113-8.
42. Patel H, Platt RW, Pekeles GS, et al. A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. J Pediatr 2002;141:818-24.
43. Hartling L, Wiebe N, Russell K, et al. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med 2003;157:957-64.
44. Hartling L, Wiebe N, Russell K, et al. Epinephrine for bronchiolitis. Cochrane Database of Systematic Reviews 2004;4:4.
45. Kneyber MCJ, Steyerberg EW, de Groot R, et al. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr 2000;89:654-60.
46. Patel H, Platt R, Lozano JM, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews 2004;4:4.
47. Perrotta C, Ortiz Z, Roque M, et al. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months. Cochrane Database of Systematic Reviews 2004;4:4.
48. Nelson M. Update on management of RSV infection, http://www.uspharmacist. com (Accessed on 25 January 2005).
49. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database of Systematic Reviews 2004;4:4.
50. Fuller H, Del Mar C. Immunoglobulin treatment for respiratory syncytial virus infection [protocol]. Cochrane Database of Systematic Reviews 2004;4:4.
51. Shah PS, Ohlsson A, Shah JP. Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children. Cochrane Database of Systematic Reviews 2003;3.
52. Beasley JM, Jones SE. Continuous positive airway pressure in bronchiolitis. BMJ Clin Res Ed 1506;283:1506-8.
53. Kong X, Fang H, Jiang G, et al. Treatment of acute bronchiolitis with Chinese herbs. Arch Dis Child 1993;68:468-71.
54. Davison CM, Ventre KMMD, Luchetti MMD, et al. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatric Critical Care Medicine 2004;5:482-9.
55. Tibby SM, Hatherill M, Wright SM, et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000;162:1251-6.
56. Martinon-Torres F, Rodriguez Nunez A, Martinon Sanchez JM. [Acute bronchiolitis: evaluation of evidence-based therapy]. An Esp Pediatr 2001;55:345-54.
57. Gupta V, Cheifetz I. Heliox administration in the pediatric intensive care unit: an evidence-based review. Pediatr Crit Care Med 2005;6:204-11.
58. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Heliox therapy in infants with acute bronchiolitis. Pediatrics 2002;109:68-73.
59. Young S, O'Keeffe P, Arnott J, et al. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child 1995;72:16-24.
60. Carbonell-Estrany X, Kimpen J. Introduction. RSV and RAD: possibilities for prevention, The link between respiratory syncytial virus and reactive airway disease. Respiratory Research 2002;3:S1-2.
61. McConnochie K, Roghmann K. Wheezing at 8 and 13 years: changing importance of bronchiolitis and passive smoking. Pediatr Pulmonol 1989;6:138-46.
62. Noble V, Murray M, Webb M, et al. Respiratory status and allergy nine to 10 years after acute bronchiolitis. Arch Dis Child 1997;76:315-19.
63. Everard M, Swarbrick A, Rigby A, et al. The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity. Respir Med 2001;95:275-80.
64. The Impact-RSV Study Group. Palivizumab, a humanised respiratory syncitial virus monoclonal antibody, reduces hospitalisation from respiratory syncitial virus infection in high risk infants. Pediatrics 1998;102:531-7.
65. Wang EEL, Tang NK. Immunoglobulin for preventing respiratory syncitial virus infection. Cochrane Database of Systematic Reviews 2004;4:4.
66. American Academy of Pediatrics. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections (2003). http://aappolicy.aappublications.org/cgi/reprint/pediatrics;112/6/1447.pdf (Accessed on 7 February 2005).
67. Joffe S, Ray GT, Escobar GJ, et al. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants. Pediatrics 1999;104:419-27.
68. Clark SJ, Beresford MW, Subhedar NV, et al. Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort. Arch Dis Child 2000;83:313-16.
69. Bala P, Ryan CA, Murphy BP. Hospital admissions for bronchiolitis in preterm infants in the absence of respiratory syncytial virus prophylaxis. Arch Dis Child Fetal Neonatal Ed 2005;90:F92.
70. Heikkinen T, Valkonen H, Lehtonen L, et al. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis. Arch Dis Child 2005;90:F64-8.
71. Prais D, Schonfeld T, Amir J. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics 2003;112:548-52.
72. Kotagal UR, Robbins JM, Kini NM, et al. Impact of a bronchiolitis guideline: a multisite demonstration project. Chest 2002;121:1789-97.
73. Perlstein PH, Kotagal UR, Bolling C, et al. Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics 1999;104:1334-41.